Finance

Lists
1752:TPE
Nang Kuang Pharmaceutical Co Ltd
NT$30,10
+0,33%
(+0,10) 1D
13 Nov., 13:30:05 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1752...
Open
NT$30,00
High
NT$30,25
Low
NT$30,00
Mkt. cap
3,04 mjd
Avg. vol.
96,74 k
Volume
26,42 k
Dividend
5,32%
Quarterly dividend
NT$0,40
Ex-dividend date
02 Jul. 2026
P/E ratio
14,83
52-wk high
NT$38,95
52-wk low
NT$28,95
EPS
NT$2,03
No. of employees
552
Open
NT$30,00
High
NT$30,25
Low
NT$30,00
Mkt. cap
3,04 mjd
Avg. vol.
96,74 k
Volume
26,42 k
Dividend
5,32%
Quarterly dividend
NT$0,40
Ex-dividend date
02 Jul. 2026
P/E ratio
14,83
52-wk high
NT$38,95
52-wk low
NT$28,95
EPS
NT$2,03
No. of employees
552
News stories
From web sources and news partners
About Nang Kuang Pharmaceutical Co Ltd
CEO-
Employees552
Founded1963
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitenangkuang.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
517,20 m
529,63 m
538,59 m
503,08 m
Cost of goods sold
336,54 m
342,12 m
340,37 m
346,41 m
Cost of revenue
336,54 m
342,12 m
340,37 m
346,41 m
Research and development expenses
38,21 m
38,12 m
44,63 m
36,32 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
79,31 m
78,63 m
77,50 m
76,94 m
Operating expense
117,52 m
116,75 m
122,14 m
113,26 m
Total operating expenses
454,06 m
458,87 m
462,52 m
459,67 m
Operating income
63,13 m
70,76 m
76,07 m
43,40 m
Other non operating income
5,33 m
2,12 m
2,23 m
-3,66 m
EBT including unusual items
76,32 m
45,21 m
64,37 m
37,70 m
EBT excluding unusual items
71,02 m
72,46 m
75,64 m
37,70 m
Income tax expense
2,97 m
13,19 m
12,63 m
8,64 m
Effective tax rate
3,90%
29,17%
19,62%
22,91%
Other operating expenses
-
-
-
-
Net income
73,82 m
32,56 m
52,37 m
29,56 m
Net profit margin
14,27%
6,15%
9,72%
5,88%
Earnings per share
-
-
-
-
Interest and investment income
1,11 m
576,00 k
1,02 m
433,00 k
Interest expense
-2,39 m
-2,26 m
-2,04 m
-2,47 m
Net interest expenses
-1,28 m
-1,68 m
-1,02 m
-2,04 m
Depreciation and amortization charges
-
-
-
-
EBITDA
107,78 m
115,20 m
121,10 m
90,55 m
Gain or loss from assets sale
-
-
-
-436,00 k
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme